NCT06382974

Brief Summary

This case series study aims to evaluate the local effects of Atorvastatin (which belongs to the family of lipid-lowering drugs, known as statins) combined with β-TCP (which is a synthetic osteoconductive bone graft), on the volume of the residual bone defects and on hastening the bone regeneration after radicular jaw cyst enucleation using CBCT-based volumetric analysis to calculate the shrinkage rate of these defects.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 22, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 25, 2024

Completed
7 months until next milestone

Study Start

First participant enrolled

December 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

August 13, 2024

Status Verified

August 1, 2024

Enrollment Period

1 year

First QC Date

April 22, 2024

Last Update Submit

August 11, 2024

Conditions

Keywords

bone regenerationbone graftvolumetric analysis

Outcome Measures

Primary Outcomes (1)

  • The Rate of shrinkage of the residual bone defect

    the shrinkage of the residual bone defects after bone grafting, measured from the following formula: pre-operative cyst volume - 3/6 months post-operative defect volume/pre-operative cyst volume x 100%. it will be measured radiographically using CBCT through manual segmentation

    3 moths post-operatively and 6 months post-operatively

Secondary Outcomes (1)

  • Incidence of Inflammation at the grafted site

    1 week post-operatively, 3 months post-operatively and 6 months post-operatively

Study Arms (1)

bone grafting using atorvastatin combined with beta-TCP

EXPERIMENTAL

the 10 volunteers will undergo cyst enucleation followed by filling the residual bone defects with atorvastatin combined with beta-TCP in the ratio of 0.1 mg: 14 mg.

Procedure: Cyst enucleation and bone grafting

Interventions

cyst enucleation followed by bone grafting the residual bone defects using Atorvastatin combined with β-TCP.

Also known as: Bone grafting
bone grafting using atorvastatin combined with beta-TCP

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male and female patients
  • Patients 18 to 40 years old
  • Radicular cyst with a maximum diameter from 1.5 to 4.0 cm;
  • Focal teeth were preserved with root canal treatment;
  • No previous surgical treatment of the cyst site;
  • No evidence of acute inflammation;
  • In good physical status and oral health;
  • Regular attendance at control visits

You may not qualify if:

  • Patients \< 17 years old
  • Radicular cyst with a maximum diameter \< 1.5 cm.
  • Pregnancy or lactation
  • Aggregate systemic pathologies such as diabetes, thyroid disorders, and bone metabolism diseases, among others;
  • Patients taking calcium, bisphosphonates, glucocorticoids, or other drugs that can interfere with the metabolism of bone;
  • Patients with uncontrolled periodontal conditions, endodontic conditions, and other oral disorders;
  • Heavy smokers (10 cigarettes/day or more)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Cairo, Egypt

Location

Related Links

MeSH Terms

Conditions

InfectionsBone Diseases, Metabolic

Interventions

Bone Transplantation

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Tissue TransplantationCell- and Tissue-Based TherapyBiological TherapyTherapeuticsOrthopedic ProceduresSurgical Procedures, OperativeTransplantation

Study Officials

  • Salah Yassin

    department of oral and maxillofacial surgery, cairo university

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: A case series study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
post-graduate master student

Study Record Dates

First Submitted

April 22, 2024

First Posted

April 25, 2024

Study Start

December 1, 2024

Primary Completion

December 1, 2025

Study Completion

March 1, 2026

Last Updated

August 13, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations